-
Abaxis Announces Stock Repurchase Program of $40M
Monday, August 8, 2011 - 6:49am | 58Abaxis, Inc. (Nasdaq: ABAX) earlier today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock. The repurchases will be made from time to time on the open market at prevailing market prices or in negotiated transactions off the...
-
China Medical Technologies and Leica Microsystems Announce Collaboration
Monday, August 8, 2011 - 6:43am | 104China Medical Technologies, Inc. (Nasdaq: CMED) and Leica Biosystems today announced that they have established a sales, research and development collaboration to co-develop and market automated FISH kits to be used on the Leica BOND system. CMED will sell the automated FISH kits in China and Leica...
-
Abaxis to Repurchase Up to $40M of its Common Stock
Monday, August 8, 2011 - 6:13am | 87Abaxis (NASDAQ: ABAX) today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock. The repurchases will be made from time to time on the open market at prevailing market prices or in negotiated transactions off the market....
-
Quidel Receives CE Mark for Its First Molecular Diagnostic Test
Friday, August 5, 2011 - 3:17pm | 174Quidel Corporation (NASDAQ: QDEL) announced today that it has received the CE Mark for the Quidel® Molecular Influenza A+B Real-Time RT-PCR Assay -- its first molecular diagnostic test. This is the first of several forthcoming Quidel Molecular Real-Time PCR Assays that provide important benefits...
-
NASDAQ Top Percentage Gainers: Web.com, SurModics, Air Transport Group, Insight Enterprises
Friday, August 5, 2011 - 2:08pm | 477POINT ROBERTS - August 5, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Aug. 04, 2011. In Thursday's session, Web.com Group was the top mover as the stock surged 19.75%. Web.com Group, Inc. (NASDAQ:...
-
Puts Purchased on Hansen Medical
Friday, August 5, 2011 - 12:29pm | 112Shares of Hansen Medical (NASDAQ: HNSN) are lower on the session by 0.60%, currently trading at $3.29. The stock has been moving largely lower over the past six weeks and is currently trading below the 50-day moving average. Options traders are buying puts on the name today. A short while ago the...
-
McNicoll, Lewis & Vlak Reiterates Rockwell Medical Buy, $16.50 PT
Friday, August 5, 2011 - 12:18pm | 101McNicoll, Lewis & Vlak reiterated its Rockwell Medical (NASDAQ: RMTI) Buy rating and $16.50 price target in a research report published today. In the report, McNicoll, Lewis & Vlak states, "RMTI recently purchased an ANDA for generic injectable Vitamin-D known as Calcitriol. RMTI expects...
-
Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Friday, August 5, 2011 - 11:33am | 124Hospira, Inc. (NYSE: HSP) today announced U.S. Food and Drug Administration approval of gemcitabine injection, a solution form of the drug. The solution presentations include 200 mg, 1 gm and 2 gm with a concentration of 38 mg/ml. The oncology medication had U.S. sales of more than $750 million in...
-
Piper Jaffray Comments On ResMed 4Q11
Friday, August 5, 2011 - 9:47am | 92According to Piper Jaffray, ResMed (NYSE: RMD) reported 4Q11 revenue slightly below estimate, but above Street consensus expectations, with a U.S. flow generator recovery and mask strength offsetting lower-than-expected ROW flow generator results. Piper Jaffray said that management described...
-
Misonix Announces Update of Product Registration in Brazil
Friday, August 5, 2011 - 8:33am | 75Misonix, Inc. (NASDAQ: MSON) has announced the completion of product registration for its BoneScalpel™ Ultrasonic Bone Cutting System in Brazil. This follows the April 21, 2011, announcement of registration completion for the SonaStar® Surgical Aspiration System in Brazil. Open market sales have...
-
Jefferies Reiterates Buy on Abiomed, Reduces PT to $18
Friday, August 5, 2011 - 8:07am | 53Jefferies reiterated its Buy rating on Abiomed (NASDAQ: ABMD). At the same time, the rating agency reduced its price target on the company's stock from $20 to $18. On Thursday, ABMD had a disastrous day as its shares lost 20.93% of their value to end the day at $12.05.
-
Jefferies Lowers PT on Abiomed To $18
Friday, August 5, 2011 - 7:00am | 26Jefferies & Company has lowered the price target on Abiomed (NASDAQ: ABMD) from $20 to $18 and maintains its Buy rating.
-
Piper Jaffray Lowers PT on ResMed To $36
Friday, August 5, 2011 - 6:43am | 26Piper Jaffray has lowered the price target on ResMed (NYSE: RMD) from $37 to $36 and maintains its Overweight rating.
-
Capitulation 08-04-2011
Thursday, August 4, 2011 - 7:17pm | 937Cusick's Corner I will not discount Chicken Little next time. Pure panic is in the market and preservation of capital is pinnacle. The reality is that the data is bad, and with the Claims Data coming in at 400K, the Non-Farm payrolls need to come in tomorrow at or above 150K. If we see 75K then...
-
Covidien Announces First Patient Enrollments in the DURABILITY Iliac and VISIBILITY Iliac Studies
Thursday, August 4, 2011 - 4:24pm | 63Covidien (NYSE: COV) today announced that the first patients have been enrolled in the DURABILITY™ Iliac and VISIBILITY™ Iliac studies. Dr. Marc Bosiers, at AZ St-Blasius, Dendermonde, Belgium, enrolled the initial patients in the DURABILITY study, while Dr. Patrick Peeters, at Imelda Hospital,...